Latest filing published 12 Aug 2025 for Nova Leap Health Corp., €605. Read the official filing
This profile gathers the share dealings of Christopher Donald Dobbin in Nova Leap Health Corp. The record holds 44 filings, for trades running from 19 February 2016 to 12 August 2025.
On the market, this insider has only ever bought: 32 purchases, €93k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 option exercises. 2025 to date brings 6 purchases and no sales.
A typical purchase (the median) is worth €2,284. Across 31 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 12 August 2025, reports an open-market purchase of €605 in Nova Leap Health Corp. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 44 declarations